| Particulars |
|
|
|
| Company Name
| Sanofi India Ltd
| Year End
| 202512
|
| Full Year |
| Equity (₹ Cr.) |
23.03 |
B.V. (₹) |
325.30 |
| Sales(₹ Cr.) |
1,837.40 |
NP (₹ Cr.) |
346.38 |
| NP Var% |
-22.00 |
Div% |
1,230.00 |
| CPS(₹) |
166.60 |
EPS (₹) |
150.40 |
| Traded Value(₹ Lakhs) |
46.39 |
52 Week High |
6,400.00 |
| 52 Week Low |
3,151.00 |
Price BSE |
3,247.00 |
| Price NSE |
3,251.00 |
Market Capital (₹ Cr.) |
7,478.88 |
| P/C Ratio |
19.50 |
P/E Ratio |
21.60 |
| Price Vs.BV |
9.98 |
|
| Latest Quarter |
| Year End |
202603 |
Sales (₹ Cr.) |
472.30 |
| NP(₹ Cr.) |
102.60 |
NP Var % |
-14.00 |
| Trailing Twelve Months |
| Year End |
202603 |
Sales |
2,192.20 |
| OPM |
24.70 |
NP |
421.55 |
| NP Var% |
-13.44 |
EPS |
142.76 |
| PE |
22.75 |
|
|